Ischemic stress induces deposition of amyloid ? immunoreactivity in human brain
The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Abstract
The histoblot immunostaining technique for locating and characterizing amyloidogenic proteins was used to obtain information about the relationship of cerebral ischemia/hypoxia to the accumulation of amyloid beta protein (A beta). We investigated brains of 131 subjects (ages 25-94 years, mean 72 years). Three distribution patterns of A beta immunoreactivity were identified: (1) colocalization with diffuse and neuritic plaques of Alzheimer's disease (AD) and aging; (2) diffuse punctuate deposits in the cerebral cortex in association with small vessel cerebral vascular disease ; and (3) cerebral cortical accumulation localized to arterial boundary zones and other regions susceptible to ischemic/hypoxic injury designated "stress-induced deposits" (SID). SID were not identified in tissue sections by immunohistochemical, Congo red or Bielschowsky silver techniques; no histological abnormalities were present in adjacent formalin-fixed tissue sections, SID occurred in subjects with histories of cerebral ischemia, and severe orthostatic hypotension. There was also an association with aging in general and with the incidence of neuritic plaques specifically. These latter findings are consistent with the hypothesis that brain ischemia/hypoxia plays a role in the pathogenesis of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, some studies (Jendroska et al., 1995; Ly et al., 2012), but not others (Aho et al., 2006; Mastaglia et al., 2003), have reported increased amyloid deposition in stroke patients, implicating that ischemia promotes AD pathology.”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Jendroska et al., 1995
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,626
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430180093036 · Cited by 1,226
FRACKOWIAK, R. S. J., POZZILLI, C., LEGG, N. J., BOULAY, G. H., MARSHALL, J., LENZI, G. L., & JONES, T. (1981) · Brain · doi:10.1093/brain/104.4.753 · Cited by 683
Evans, D. A., Funkenstein, H. H., Albert, M., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., & Taylor, J. O. (1989) · PubMed · Cited by 599
Cited by
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
γ-Secretase in Alzheimer’s disease
Hur, J.-Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00754-8 · Cited by 310
Mandel, S., Amit, T., Reznichenko, L., Weinreb, O., & Youdim, M. B. H. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500156 · Cited by 291
Atwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
Update on hypertension and Alzheimer's disease
Skoog, I., & Gustafson, D. (2006) · Neurological Research · doi:10.1179/016164106x130506 · Cited by 294
Statins for the treatment of dementia
McGuinness, B., Craig, D., Bullock, R., Malouf, R., & Passmore, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514.pub3 · Cited by 216
Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes
Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., & Hsu, C. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0001.2001 · Cited by 230
Kelleher, R. J., & Soiza, R. L. (2013) · Europe PMC (PubMed Central) · Cited by 271
Daulatzai, M. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23634 · Cited by 217
Neuroprotective Herbs and Foods from Different Traditional Medicines and Diets
Iriti, M., Vitalini, S., Fico, G., & Faoro, F. (2010) · Molecules · doi:10.3390/molecules15053517 · Cited by 182
Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9360-7 · Cited by 180
Kontush, A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00688-8 · Cited by 177
Status of Risk Factors for Vascular Dementia
Skoog, I. (1998) · Neuroepidemiology · doi:10.1159/000026147 · Cited by 178
Yang, S.-P., Bae, D.-G., Kang, H. J., Gwag, B. J., Gho, Y. S., & Chae, C.-B. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00111-8 · Cited by 169
Bar‐Am, O., Weinreb, O., Amit, T., & Youdim, M. B. H. (2005) · The FASEB Journal · doi:10.1096/fj.05-3794fje · Cited by 165
Brain Microvascular Changes in Alzheimer's Disease and Other Dementiasa
BUÉE, L., HOF, P. R., & DELACOURTE, A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48457.x · Cited by 165
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
Lopez, O. L., Kuller, L. H., Mehta, P. D., Becker, J. T., Gach, H. M., Sweet, R. A., Chang, Y. F., Tracy, R., & DeKosky, S. T. (2008) · Neurology · doi:10.1212/01.wnl.0000306696.82017.66 · Cited by 161
Vascular Aspects of Cognitive Impairment and Dementia
Wiesmann, M., Kiliaan, A. J., & Claassen, J. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.159 · Cited by 143
Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic Stroke
Thiel, A., Cechetto, D. F., Heiss, W., Hachinski, V., & Whitehead, S. N. (2014) · Stroke · doi:10.1161/strokeaha.114.004285 · Cited by 156
Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 157
Alzheimer's Mechanisms in Ischemic Brain Degeneration
Pluta, R., Ułamek, M., & Jabłoński, M. (2009) · The Anatomical Record · doi:10.1002/ar.21018 · Cited by 133
Vascular risk factors and Alzheimer’s disease
Cechetto, D. F., Hachinski, V., & Whitehead, S. N. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.743 · Cited by 129
Hypercholesterolaemia and vascular dementia
Appleton, J. P., Scutt, P., Sprigg, N., & Bath, P. M. (2017) · Clinical Science · doi:10.1042/cs20160382 · Cited by 126
Hemodynamic Consequences of Deformed Microvessels in the Brain in Alzheimer's Disease
de la TORRE, J. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48462.x · Cited by 127
The blood brain barrier in Alzheimer’s disease
Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118
Pluta, R., Furmaga-Jabłońska, W., Maciejewski, R., Ułamek-Kozioł, M., & Jabłoński, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8360-z · Cited by 114
Nitric oxide from inflammatory‐activated glia synergizes with hypoxia to induce neuronal death
Mander, P., Borutaite, V., Moncada, S., & Brown, G. C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20285 · Cited by 117
Chen, G.-J., Xu, J., Lahousse, S. A., Caggiano, N. L., & de la Monte, S. M. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5305 · Cited by 115
Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya
Cuajungco, M. P., & Lees, G. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00463-6 · Cited by 127
Death by a Thousand Cuts in Alzheimer’s Disease: Hypoxia—The Prodrome
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9379-2 · Cited by 121
Characteristics of thein VitroVasoactivity of β-Amyloid Peptides
Crawford, F., Suo, Z., Fang, C., & Mullan, M. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6743 · Cited by 112
Hypertension, hypertension-clustering factors and Alzheimer's disease
Skoog, I., & Gustafson, D. (2003) · Neurological Research · doi:10.1179/016164103101201986 · Cited by 109
Plants-derived neuroprotective agents: cutting the cycle of cell death through multiple mechanisms
Elufioye, T. O., Berida, T. I., & Habtemariam, S. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/3574012 · Cited by 107
“Interestingly, the deposition of both Aβ and APP in the cortical and subcortical brain areas of nondementia patients following stroke has been reported [37].”
BackgroundThe effects of cardiovascular risk factors on cognitive compromise
Beeri, M. S., Ravona-Springer, R., Silverman, J. M., & Haroutunian, V. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/msbeeri · Cited by 99
Pluta, R., Jabłoński, M., Ułamek-Kozioł, M., Kocki, J., Brzozowska, J., Januszewski, S., Furmaga-Jabłońska, W., Bogucka-Kocka, A., Maciejewski, R., & Czuczwar, S. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8439-1 · Cited by 99
Popa-Wagner, A., Schröder, E., Walker, L. C., & Kessler, C. (1998) · Stroke · doi:10.1161/01.str.29.10.2196 · Cited by 100
Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
Kovács, G. G., Botond, G., & Budka, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0658-1 · Cited by 110
Mechanisms of amyloid plaque pathogenesis
Fiala, J. C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0284-8 · Cited by 112
Radenović, L., Nenadić, M., Ułamek-Kozioł, M., Januszewski, S., Czuczwar, S. J., Anđjus, P. R., & Pluta, R. M. (2020) · Aging · doi:10.18632/aging.103411 · Cited by 103
Non-psychiatric comorbidity associated with Alzheimer's disease
Duthie, A., Chew, D., & Soiza, R. L. (2011) · QJM · doi:10.1093/qjmed/hcr118 · Cited by 95
Statins for the treatment of dementia
McGuinness, B., O'Hare, J., Craig, D., Bullock, R., Malouf, R., & Passmore, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007514.pub2 · Cited by 92
Whitehead, S. N., Cheng, G., Hachinski, V., & Cechetto, D. F. (2007) · Stroke · doi:10.1161/strokeaha.107.492660 · Cited by 84
The role of iron as a mediator of oxidative stress in Alzheimer disease
Castellani, R. J., Moreira, P. I., Perry, G., & Zhu, X. (2012) · BioFactors · doi:10.1002/biof.1010 · Cited by 81
Hellweg, R., Gericke, C. A., Jendroska, K., Hartung, H.-D., & Cervós‐Navarro, J. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00088-4 · Cited by 90
Self-citationWu, Y., Bogale, T. A., Koıstınaho, J., Pizzi, M., Rõlova, T., & Bellucci, A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02696-z · Cited by 91
Amyloid β Peptide and Precursor Protein (APP) in Mild and Severe Brain Ischemia
Jendroska, K., Hoffmann, O. M., & Patt, S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48492.x · Cited by 81
Self-citationThe state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 87
Tau Protein Dysfunction after Brain Ischemia
Pluta, R. M., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180772 · Cited by 76
Vascular aspects in Alzheimer’s disease
Skoog, I. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_6 · Cited by 71
Orthostatic hypotension and attention in Parkinson’s disease with and without dementia
Peralta, C., Stampfer‐Kountchev, M., Karner, E., Köllensperger, M., Geser, F., Wolf, E., Seppi, K., Benke, T., Poewe, W. H., & Wenning, G. K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0615-2 · Cited by 77
Self-citationBadan, I., Dinca, I., Buchhold, B., Suofu, Y., Walker, L., Gratz, M., Platt, D., Kessler, C., & Popa‐Wagner, A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03323.x · Cited by 70
Kim, Y. J., Kim, S. M., Jeong, D. H., Lee, S.-K., Ahn, M.-E., & Ryu, O.-H. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00620-5 · Cited by 68
Brain Ischemia as a Prelude to Alzheimer's Disease
Pluta, R., Januszewski, S., & Czuczwar, S. J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.636653 · Cited by 67
The dark sides of amyloid in Alzheimer's disease pathogenesis
Sorrentino, P., Iuliano, A., Polverino, A., Jacini, F., & Sorrentino, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.12.038 · Cited by 63
Glushakova, O., Glushakov, A. V., Glushakov, A. O., Wijesinghe, D. S., Valadka, A. B., & Hayes, R. (2017) · Brain Circulation · doi:10.4103/bc.bc_27_16 · Cited by 67
Amyloid and lipids in the pathology of Alzheimer disease
Roher, A. E., Kuo, Y.-M., Kokjohn, K. M., Emmerling, M. R., & Gracon, S. (1999) · Amyloid · doi:10.3109/13506129909007315 · Cited by 63
Effect of HMG-CoA Reductase Inhibitors on ??-Amyloid Peptide Levels
Höglund, K., & Blennow, K. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00002 · Cited by 75
Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
Lee, H., Castellani, R. J., Zhu, X., Perry, G., & Smith, M. A. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00429.x · Cited by 61
Meier-Ruge, W., & Bertoni-Freddari, C. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.1.1 · Cited by 60
Zhen, G., Kim, Y. T., Li, R.-C., Yocum, J., Kapoor, N., Langer, J., Dobrowolski, P., Maruyama, T., Narumiya, S., & Doré, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.017 · Cited by 58
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
Jeong, H., Shin, H., Hong, S., & Kim, Y. S. (2022) · Experimental Neurobiology · doi:10.5607/en22004 · Cited by 65
PET imaging of the neurovascular interface in cerebrovascular disease
Evans, N. R., Tarkin, J. M., Buscombe, J. R., Markus, H. S., Rudd, J. H. F., & Warburton, E. A. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.129 · Cited by 61
Kerridge, C., Kozlova, D. I., Nalivaeva, N. N., & Turner, A. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00426 · Cited by 52
Orthostatic hypotension and cognition in older adults: A systematic review and meta-analysis
Iseli, R. K., Nguyen, V., Sharmin, S., Reijnierse, E. M., Lim, W. K., & Maier, A. B. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.02.017 · Cited by 56
Clarke, J., Thornell, A., Corbett, D., Soininen, H., Hiltunen, M., & Jolkkonen, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05807.x · Cited by 50
Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration
Pluta, R. M., Januszewski, S., & Czuczwar, S. J. (2021) · Nutrients · doi:10.3390/nu13020342 · Cited by 50
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130920 · Cited by 46
Amyloid β‐peptide and the dementia of Parkinson's diease
Jendroska, K., Lees, A. J., Poewe, W. H., & Daniel, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110609 · Cited by 49
Self-citationPluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124002 · Cited by 45
Bottero, V., & Potashkin, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215403 · Cited by 44
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030892 · Cited by 47
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020517 · Cited by 44
Prion Disease Induces Alzheimer Disease—Like Neuropathologic Changes
Tousseyn, T., Bajsarowicz, K., Sánchez, H., Gheyara, A., Oehler, A., Geschwind, M., DeArmond, B., & DeArmond, S. J. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000228 · Cited by 42
Self-citationIs Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?
Ouyang, F., Jiang, Z., Chen, X., Chen, Y., Wei, J., Xing, S., Zhang, J., Fan, Y., & Zeng, J. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00921-5 · Cited by 43
β-Amyloid Aggregation in Human Brains With Cerebrovascular Lesions
Aho, L., Jolkkonen, J., & Alafuzoff, I. (2006) · Stroke · doi:10.1161/01.str.0000248777.44128.93 · Cited by 40
Bürger, S., Noack, M., Kirazov, L. P., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.011 · Cited by 42
Gold, G., Giannakopoulos, P., & Bouras, C. (1998) · European Neurology · doi:10.1159/000007968 · Cited by 41
Pluta, R. M., Ułamek-Kozioł, M., Januszewski, S., & Czuczwar, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134599 · Cited by 38
Göttler, J., Preibisch, C., Riederer, I., Pasquini, L., Alexopoulos, P., Bohn, K. P., Yakushev, I. Y., Beller, E., Kaczmarz, S., Zimmer, C., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18759182 · Cited by 40
Wei, X., Huang, G., Liu, J., Ge, J., Zhang, W., & Mei, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114619 · Cited by 37
Meier‐Ruge, W., & Bertoni–Freddari, C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48474.x · Cited by 38
Ly, J. V., Rowe, C. C., Villemagne, V. L., Zavala, J. A., Ma, H., Sahathevan, R., O'Keefe, G. J., Gong, S. J., Gunawan, R., Churilov, L. P., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.636266 · Cited by 38
Emerging evidence for the neuroprotective role of α-synuclein
Lee, H., Zhu, X., Takeda, A., Perry, G. L., & Smith, M. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.024 · Cited by 45
Alzheimer's Amyloid-β as a Preventive Antioxidant for Brain Lipoproteins
Kontush, A. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1012629603390 · Cited by 36
Gren, M., Shahim, P., Lautner, R., Wilson, D. H., Andréasson, U., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Brain Injury · doi:10.1080/02699052.2016.1179792 · Cited by 35
The immunology of stroke and dementia
Iadecola, C., & Anrather, J. (2025) · Immunity · doi:10.1016/j.immuni.2024.12.008 · Cited by 41
Pluta, R. M., Jabłoński, M., & Czuczwar, S. J. (2012) · PubMed · Cited by 34
Current Alzheimer disease research highlights: evidence for novel risk factors
Brenowitz, W. D., Xiang, Y., McEvoy, C. T., Yang, C., Yaffe, K. S., Le, W., & Leng, Y. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001706 · Cited by 35
Pluta, R. M., & Amek, M. U. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3739 · Cited by 36
Pluta, R. M., Ouyang, L., Januszewski, S., Li, Y., & Czuczwar, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052460 · Cited by 37
Pluta, R. M., Kiś, J., Januszewski, S., Jabłoński, M., & Czuczwar, S. J. (2022) · Antioxidants · doi:10.3390/antiox11010146 · Cited by 37
Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer’s Disease Proteinopathy
Pluta, R. M., Januszewski, S., & Czuczwar, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010306 · Cited by 31
Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus
Ishimaru, H., Uéda, K., Takahashi, A., & Maruyama, Y. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00033-x · Cited by 30
A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes
Heininger, K. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199912)14:8<525::aid-hup140>3.0.co;2-t · Cited by 30
Aβ Deposits in the Neocortex of Adult and Infant Hypoxic Brains, Including in Cases of COVID-19
Priemer, D. S., Rhodes, C. H., Karlovich, E., Perl, D. P., & Goldman, J. E. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac095 · Cited by 26
A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model
Pluta, R. M. (2024) · Current Alzheimer Research · doi:10.2174/0115672050320921240627050736 · Cited by 29
Whitehead, S. N., Massoni, E., Cheng, G., Hachinski, V., Cimino, M., Balduini, W., & Cechetto, D. F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.008 · Cited by 26
Metadata
- Authors
- Jendroska, K., Poewe, W., Pluess, J., Iwerssen-Schmidt, H., Paulsen, J., Barthel, S., Schelosky, L., Cerv�s-Navarro, J., Daniel, S. E., & DeArmond, S. J.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Parkinson's UK (GB)
- University of California, San Francisco (US)
- Venue
- Acta Neuropathologica
- Published
- 1995-11
- Volume
- 90
- Issue
- 5
- Pages
- 461-466
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1978105781
- Cited by
- 163
- References
- 27
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 9 · 2021: 10 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 3 · 2013: 9 · 2012: 6
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- amyloid-beta, cerebral ischemia, hypoxia, Alzheimer's disease, neuritic plaques, cerebrovascular disease, orthostatic hypotension, brain aging, cerebral cortex, amyloid deposition
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Cerebral Cortex, Brain Ischemia, Humans, Immunohistochemistry, Middle Aged, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.